![]() |
市场调查报告书
商品编码
1382480
子宫肌瘤切除术市场 - 按产品、类型、最终用途 - 到 2032 年的全球预测Myomectomy Market - By Product, By Type, By End-use - Global Forecast to 2032 |
在机器人辅助和微创技术等先进手术技术的不断开发和采用的推动下,子宫肌瘤切除术市场规模预计从 2023 年到 2032 年将以 8.6% 的CAGR扩大。机器人辅助手术、腹腔镜检查和先进影像技术的高度整合等创新正在改变对子宫肌瘤切除术的需求,以提高精确度、减少侵入性并缩短恢復时间,从而改善患者的治疗效果。
此外,外科医生在手术过程中受益于改进的可视化和控制,进一步促进了对技术先进方法的日益增长的偏好。例如,2022 年 11 月,奥林巴斯推出了新的微创手术替代方案 moresolution (TM) Power Morcellator,由 TROKAMED GmbH 生产,适用于接受低风险子宫切除术或子宫肌瘤切除术的患者。随着医疗保健产业的不断转型,市场有望实现稳定成长。
子宫肌瘤切除术产业按产品类型、最终用途和地区细分。
根据产品类型,从 2023 年到 2032 年,谐波手术刀细分市场的市场规模可能会呈现 8.2% 的CAGR。谐波手术刀因其在子宫肌瘤切除术中提供精确性和微创性而受到关注,可减少失血并促进患者康復。随着医疗保健提供者优先考虑先进技术来优化手术干预,对谐波手术刀的需求预计将会上升,以减少热扩散并改善可视化,从而改善手术结果。
就最终用途而言,门诊手术中心 (ASC) 领域的子宫肌瘤切除术行业预计在 2023 年至 2032 年间实现 8.5% 的CAGR。由于住院费用降低和恢復时间加快,人们对门诊手术的偏好日益增加,这将有助于细分市场成长。与传统医院环境相比,ASC 为子宫肌瘤切除手术提供了更方便且更具成本效益的环境。为患者提供的可近性和效率以及为医疗保健提供者提供的简化工作流程将促进该细分市场的成长。
从地区来看,亚太地区子宫肌瘤切除术市场在2022 年占据了相当大的收入份额,由于人们的意识不断提高、子宫肌瘤患病率不断上升以及医疗基础设施的进步,预计到2032 年将实现稳定成长。此外,随着越来越多的女性寻求先进的医疗解决方案,中国和印度对子宫肌瘤切除术的需求尤其增长。有利的政府措施的涌入和创新外科技术的大量采用将进一步推动该地区行业的成长。
Myomectomy Market size is poised to expand at 8.6% CAGR from 2023-2032 driven by the ongoing development and adoption of advanced surgical technologies, such as robotic-assisted and minimally invasive techniques. Innovations, including robotic-assisted surgery, laparoscopy, and higher integration of advanced imaging techniques are transforming the demand for myomectomy procedures to offer increased precision, reduced invasiveness, and shorter recovery times for enhanced patient outcomes.
Moreover, surgeons are benefiting from improved visualization and control during the procedures, further contributing to the growing preference for technologically advanced approaches. For instance, in November 2022, Olympus introduced its new minimally invasive surgery alternative, moresolution™ Power Morcellator, produced from TROKAMED GmbH for patients undergoing low-risk hysterectomy or myomectomy. With the rising transformation of the healthcare sector, the market is poised to witness steady growth.
The myomectomy industry is segmented into product type, end-use, and region.
Based on product type, the market size from the harmonic scalpel segment is likely to showcase 8.2% CAGR from 2023-2032. Harmonic scalpel has gained prominence as it offers precision and minimal invasiveness in myomectomy procedures for reducing blood loss and enhancing patient recovery. With healthcare providers prioritizing advanced technologies to optimize surgical interventions, the demand for harmonic scalpels is expected to rise to offer reduced thermal spread and improved visualization for improved surgical outcomes.
In terms of end-use, the myomectomy industry from the ambulatory surgical centers (ASC) segment is set to attain 8.5% CAGR between 2023 and 2032. The increasing preference for outpatient procedures due to reduced hospitalization costs and quicker recovery times will contribute to the segment growth. ASCs offer more convenient and cost-effective environment for myomectomy procedures compared to traditional hospital settings. The accessibility and efficiency offered to patients and the access to streamlined workflow to healthcare providers will add to the segment growth.
Regionally, the Asia Pacific myomectomy market held sizable revenue share in 2022 and is estimated to record steady growth through 2032 owing to increasing awareness, the rising prevalence of uterine fibroids, and higher advancements in healthcare infrastructure. Additionally, with the growing female population seeking advanced healthcare solutions, the demand for myomectomy procedures is particularly rising in China and India. The influx of favorable government initiatives and the surging adoption of innovative surgical technologies will further propel the regional industry growth.